Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,331
Closed -$337K 755
2025
Q4
$337K Buy
1,331
+127
+11% +$31.9K 0.01% 491
2025
Q3
$298K Buy
1,204
+237
+25% +$56.7K 0.01% 501
2025
Q2
$232K Buy
+967
New +$225K 0.01% 525
2022
Q4
Sell
-11
Closed -$2K 1044
2022
Q3
$2K Sell
11
-26
-70% -$5.29K ﹤0.01% 1074
2022
Q2
$8K Buy
37
+18
+95% +$4.06K ﹤0.01% 814
2022
Q1
$5K Buy
19
+9
+90% +$2.09K ﹤0.01% 921
2021
Q4
$2K Hold
10
﹤0.01% 1072
2021
Q3
$2K Hold
10
﹤0.01% 1029
2021
Q2
$2K Hold
10
﹤0.01% 1071
2021
Q1
$2K Hold
10
﹤0.01% 1056
2020
Q4
$2K Hold
10
﹤0.01% 909
2020
Q3
$2K Hold
10
﹤0.01% 869
2020
Q2
$2K Buy
+10
New +$1.52K ﹤0.01% 902
2019
Q4
Sell
-43,785
Closed -$6.33M 1447
2019
Q3
$6.33M Buy
+43,785
New +$6.54M 0.78% 20

Other funds holding STE

Evoke Wealth's STE Position: Q1 2026 in Review

Evoke Wealth sold out of Steris (STE) in Q1 2026, closing a stake of 1,331 shares — an estimated $337K sold.

Evoke Wealth first reported a position in STE in Q3 2019 and held it in 14 quarters. The position peaked at $6.33M in Q3 2019. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Evoke Wealth reported no remaining Steris position as of Q1 2026 after selling out during the quarter.
  • Evoke Wealth sold 1,331 Steris shares in Q1 2026, an estimated $337K.
  • Evoke Wealth first reported a position in Steris in Q3 2019 and held it in 14 quarters.
  • Evoke Wealth's Steris position peaked at $6.33M in Q3 2019.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Evoke Wealth's 13F filing for Q1 2026, filed 15 May 2026.